Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Further analysis of KIFAP3 gene in ALS patients from Switzerland and Sweden.
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
Three-dimensional rotational angiography of the left atrium and esophagus--A virtual computed tomography scan in the electrophysiology lab?
Association of negative financial shocks during the Great Recession with depressive symptoms and substance use in the USA: the CARDIA study.
Overcoming barriers to biosimilars in inflammatory arthritis.
See All 13 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Overcoming barriers to biosimilars in inflammatory arthritis.
Kay J. Overcoming barriers to biosimilars in inflammatory arthritis. Nat Rev Rheumatol. 2020 Feb; 16(2):65-66.
View in:
PubMed
subject areas
Arthritis
Biosimilar Pharmaceuticals
Cost-Benefit Analysis
European Union
Humans
Legislation, Drug
Observational Studies as Topic
Randomized Controlled Trials as Topic
Treatment Outcome
authors with profiles
Jonathan Kay MD